Main Article Content
Background: Acne is one of the most common dermatological conditions encountered in day to day practice. Many recent studies have reported a strong association between acne and underlying systemic endocrine disorders, more particularly Polycystic ovarian syndrome.
Objective: To study the association between acne and polycystic ovarian syndrome, in women presenting with adult onset acne and its associated factors with regard to the clinical findings.
Study Design: This was a cross –sectional study.
Place and Duration of Study: Department of Dermatology at Tishreen University Hospital, Lattakia, Syria, from January 2018 to February 2019.
Methodology: Total of 150 female patients aged 18-43 years, with various degree of acne did not receive hormonal treatment, including hormonal contraceptive and antiandrogen therapy, for at least 3 months prior to study. Each participant was evaluated by complete medical history, detailed dermatological examination, abdominal ultrasound examination and hormonal assays. The presence of PCOS was assessed using Rotterdam criteria 2003.
Results: The final analysis had included 150 women with acne. The proportion with mild, moderate, severe and very severe acne was 56%, 30%, 11% and 3% respectively. The prevalence of PCOS was 34%. PCOS had shown no statistically significant association with severity of acne or total testosterone concentration (p value >0.05). The factors which have shown statistically significant association were late onset acne above 25 years, irregularity of menstrual cycle, presence of Hirsutism, higher BMI and higher waist circumference.
Conclusion: PCOS is a common disorder among women with acne vulgaris. However it is not related to the severity of acne. Presence of menstrual disturbance, hirsutism, obesity are strong risk factors for PCOS. Early diagnoses and treatment can avoid the possible complications.
Fitzpatrick TB, Johnson RA, Wolff K. Disorders of sebaceous and apocrine glands. In: Fitzpatrick TB, Johnson RA, Wolff K, Editors. Colour atlas and synopsis of clinical dermatology. 7th Ed. McGRAW-Hill; New York. 2013;2-17.
Zaidi Z. Acne vulgaris-an update on pathophysiology and treatment. J Pak Med Assoc. 2009;59(9):635-7.
Essah PA, Wickham EP 3rd, Nunley JR, Nestler JE. Dermatology of androgen-related disorders. Clin Dermatol. 2006;24: 289-98.
Shaw JC. Acne: Effect of hormones on pathogenesis and management. Am J Clin Dermatol. 2002;3:571-8.
Timpatanapong P, Rojanasakul A. Hormonal profiles and prevalence of polycystic ovary syndrome in women with acne. J Dermatol. 1997;24:223-9.
Moura HH, Costa DL, Bagatin E, Sodre` CT, Manela-Azulay M. Polycystic ovary syndrome: A dermatologic approach. An Brass Dermatol. 2011;86:111-9.
Azziz R, Carmina E, Kandarakis DE, Morreale EF, Futterweit W, Janssen EO, et al. Criteria for defining PCOS as a predominantly hyperandrogenic syndrome: An androgen excess society guidelines. J Clin Endocrinol Metab. 2006;91:423-7.
Lo JC, Feigenbaum SL, Yang J, Pressman AR, Selby JV, Go AS. Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91:1357-63.
Zandi S, Farajzadeh S, Safari H. Prevalence of polycystic ovary syndrome in women with acne: Hormone profiles and clinical findings. J Pak Assoc Dermatol. 2016;20:194-8.
The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19-25.
Balen AH, Laven JS, Tan SL, et al. Ultrasound assessment of the polycystic ovary: International consensus definitions. Hum Reprod Update. 2003;9:505–14.
IBMCorp. IBM SPSS Statistics for Windows. 21.0 Ed. Armonk, NY: IBM Corp; 2012.
Homburg R. Polycystic ovary syndrome – from gynecological curiosity to multisystem endocrinopathy. Hum Reprod. 1996;11: 29–39.
Zandi S, Farajzadeh S, Safari H. Prevalence of polycystic ovary syndrome in women with acne: Hormone profiles and clinical findings. J Am Acad Dermatol. 2016;20(4):194-8.
Begum S, Hossain MZ, Rahman MF, Banu LA. Polycystic ovarian syndrome in women with acne. J Pak Assoc Dermatol. 2012;22:24-9.
Cunliffe WJ, Holland DB, Jeremy A. Comedone formation: Etiology, clinical presentation and treatment. Clin Dermatol. 2004;22:367-74.
Fraser IS, Kovacs G. Current recommendations for the diagnostic evaluation and follow-up of patients presenting with symptomatic polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol. 2004;18:813-23.
Maluki AH. The frequency of polycystic ovary syndrome in females with resistant acne vulgaris. J Cosmet Dermatol. 2010;9(2):142-8.
Sadia Jabeen, Faria Asad, Zahida Rani, Khawar Khurshid, Sabrina Suhail Pal. Frequency of polycystic ovarian syndrome among patients presenting with acne. Journal of Pakistan Association of Dermatologists. 2018;28(3):329-332.
Sharquie KE, Al-Bayatti AA, Al-Ajeel AI, et al. The frequency of skin manifestations among patients with polycystic ovary syndrome. Saudi Med J. 2007;28:1039–43.
Hopkinson Z, Satter N, Fleming R. Polycystic ovary syndrome: The metabolic syndrome comes to gynecology. BMJ. 1998;317:329–32.
Raja Shareef A, Prasad PVS, Kaviarasan PK. Prevalence and pattern of PCOS in women presenting with acne, hospital based prospective observational study. International Journal of Research in Medical Sciences. 2018;6(3):899-903.
Norman RJ, Dewailly D, Legro RS, et al. Polycystic ovary syndrome. Lancet. 2007;370:685–97.